Repligen
Repligen is a bioprocessing-focused life sciences company that seeks to develop and commercialize specialty products, and provide biotechnology services, principally in the area of monoclonal antibodies.
The company's manufacturing facilities are located in the USA, Sweden and Germany. Repligen markets its products globally through a direct commercial organization in the USA, Europe and Asia, as well as through strategic partners in certain markets.
Latest Repligen News & Features
28 June 2017
3 February 2015
21 January 2015
23 January 2014
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze